Folliculitis, furuncle and carbuncle

Meet the patient

A 22-year-old rugby player arrives with his third painful boil on his thigh in two months, each one a deep, tender, red nodule that comes to a yellow point and bursts. This one has a necrotic centre. His housemate had a similar lesion last month. He is otherwise well, but the recurrence is wearing him down.[1][2]

Three questions now frame the whole topic: is the lesion fluctuant? (it is — so it needs drainage), is this recurrent PVL S. aureus? (a young athlete with necrotic, clustered lesions says yes), and where is the reservoir? (his nose, and his housemate). Drain it, swab for PVL, and start decolonisation — the antibiotics alone will not stop the cycle.[1][6]

The spectrum — one disease, three depths

The single most useful concept is that folliculitis, furuncle and carbuncle are one infection at increasing depth, all follicle-centred and almost all staphylococcal. Recognise the depth and you have chosen the treatment.[1][17]

Superficial folliculitis is a tiny follicle-centred pustule at the ostium — itchy, often in areas of friction, shaving, occlusion or heat. A furuncle (boil) is the acute deep extension: a tender, firm, red nodule that becomes fluctuant, develops a central yellow punctum, and ruptures to discharge pus and a necrotic core. A carbuncle is the coalescence of interconnected furuncles draining through several openings, classically on the nape, back or thighs, with systemic upset and scarring.[1][18]

The cilium-bearing follicle is a niche that shelters bacteria from surface antiseptics. Shaving, friction and occlusion disrupt the follicular barrier; S. aureus adhesins (teichoic acid, fibronectin-binding protein A) tether it to the corneocyte, neutrophils rush in to make the pustule, and when the follicular wall ruptures the keratin, bacteria and lipoid contents spill into the dermis to forge the deep necrotic nodule.[1][6]

Etymology for viva gold: furuncle comes from the Latin furunculus, "a little thief" — medieval physicians thought the boil stole health from the body. Carbuncle is from the Latin carbunculus, "a small coal", because the clustered, draining abscess glowed red like embers. Both names are six centuries old and still describe the lesion exactly.[1]

Staphylococcus aureus and the special pathogens

S. aureus causes the great majority of folliculitis, furuncles and carbuncles — but a cluster of special pathogens changes both the look and the treatment, and examiners test each of them. Cluster the non-staphylococcal causes by their giveaway.[1][6]

[1] [6] [10]

PVL S. aureus — the toxin that drives recurrence

Panton-Valentine leucocidin (PVL)-producing S. aureus is the answer whenever a young, otherwise well patient has recurrent, multiple, necrotic furunculosis, and it is dangerous because the same toxin causes necrotising pneumonia. It can be MSSA or MRSA — the PVL status matters more than the methicillin status.[6][7]

PVL is a pore-forming, bi-component leucocidin encoded by the lukS-PV and lukF-PV genes that lyses neutrophils and macrophages, driving the necrotic phenotype. Suspect it in athletes, household clusters, and severe solitary lesions — and add PVL PCR to the swab. PVL-positive strains are also linked to bone and joint infections and to severe community-acquired pneumonia after influenza.[6][7]

The management principle is that a toxin-suppressing antibiotic must be added to drainage: clindamycin or linezolid suppress exotoxin synthesis, and rifampicin-based regimens help eradicate carriage. Knowing MSSA versus MRSA is not enough — PVL-positive strains of either background need toxin suppression.[5][6]

The bedside — fluctuance decides drainage

The single most useful bedside distinction is fluctuance: a fluctuant lesion of any size needs drainage, not antibiotics alone. Confirm it with the pinch test or the needle-aspiration test (an 18 G needle on a 10 mL syringe returning pus under pressure).[1][18]

Seek the portal of entry (shaving, occlusion, hot-tub exposure, contact sport, IVDU), the carrier status (examine the anterior nares), and the predisposing disease — diabetes, HIV, iron deficiency, atopic eczema, immunosuppression. In recurrent disease, swab the nose, perineum and axillae, and screen HbA1c, HIV serology, FBC and iron studies.[1][2]

The classic trap: incising a lesion that is not a furuncle — herpetic whitlow, an inflamed epidermoid cyst, hidradenitis suppurativa, or a deep mycosis. Always review the morphology before a blade reaches the skin; if the picture does not fit a staphylococcal boil, biopsy or re-diagnose first.[1][18]

Management — incision and drainage is primary

[1]

The Cochrane review is unequivocal: incision and drainage is the primary and most important therapy for a fluctuant furuncle or carbuncle, and antibiotics are adjunctive. The benefit of added antibiotics over placebo is modest for uncomplicated lesions, and antibiotic choice is guided by severity, immune status and local resistance.[1]

Superficial folliculitis is often self-limiting: warm compresses, chlorhexidine 4 percent wash once daily for 1 to 2 weeks, and topical mupirocin 2 percent BD to TDS for 7 to 10 days (or topical clindamycin 1 percent) for limited staphylococcal disease. Address shaving technique — leave stubble, use a sharp blade, shave with the grain.[1][18]

Incision and drainage — the technique that wins marks:[1]

• Pre-procedure — local anaesthetic (1 percent lidocaine without adrenaline), chlorhexidine antisepsis, map the loculi with the pinch test for a carbuncle.
• Incision — a number-11 blade makes a linear stab across the point of maximum fluctuance; a cruciate (cross) incision for a carbuncle drains the connected loculi.
• Evacuate and sample — express pus with gloved pressure, send the necrotic core to microbiology, and place a 14 to 16 Fr drain or iodoform wick to prevent premature cavity closure.
• Aftercare — irrigate with saline, review at 48 to 72 hours, replace the drain at 24 to 48 hours, and let the cavity heal by secondary intention.

[1] [17]

Adjunctive oral antibiotics are indicated for surrounding cellulitis, systemic symptoms (fever), immunocompromise, diabetes, large lesions, facial or danger-triangle lesions, failure of drainage alone, and recurrent disease. Choose an oral anti-staphylococcal agent — flucloxacillin or cephalexin for MSSA, and clindamycin, TMP-SMX or doxycycline for suspected MRSA or PVL strains.[5][3]

The doses — the numbers examiners quote:[1][5]

[1] [5] [6]

Recurrent furunculosis — break the cycle with decolonisation

Recurrent furunculosis — three or more episodes in 12 months — is driven by S. aureus carriage plus a predisposing disease, and it is broken by decolonisation, not by repeated antibiotic courses. Without decolonisation, recurrence runs about 50 percent within a year; with combined decolonisation and household-contact treatment it falls to 10 to 20 percent.[2][4]

The decolonisation regimen:[3][4]

• Intranasal mupirocin 2 percent to both anterior nares, twice daily for 5 days.
• Chlorhexidine 4 percent body wash or dilute bleach baths (a quarter-cup of household bleach per full bath), daily for 5 to 7 days then weekly maintenance.
• Wash towels, sheets and flannels at 60 degrees Celsius daily during the regimen, and stop sharing razors and personal items.
• Treat household contacts if nose swabs are positive — they are the reservoir that re-seeds the patient.
• Optimise the predisposing disease — glycaemic control, ART adherence, iron replacement, weight, and hygiene.

[2] [3] [4]

For proven PVL disease, eradicate carriage aggressively once lesions have healed; recurrence within 3 to 6 months prompts a repeat regimen plus consideration of low-dose clindamycin 150 mg at night for 3 months or monthly TMP-SMX.[1][6]

The danger triangle — cavernous sinus thrombosis

Take two peripheral blood culture sets in any patient with fever or systemic features, because S. aureus bacteraemia seeds metastatically — endocarditis, vertebral osteomyelitis, septic pulmonary emboli and septic arthritis, especially with PVL strains. Echocardiography for persistent bacteraemia or a new murmur; spine MRI for back pain; PET-CT for occult foci when fever persists beyond 7 days.[8][9]

The differential — folliculitis versus its mimics

The follicular pustule has a cluster of mimics, and the depth and tempo prise them apart. The culture and the morphology do the work.[1][18]

[1] [18]

Traps, confessions and preventable harm

Everyone reaches for antibiotics and forgets the blade. That is how a fluctuant abscess gets under-treated. Drainage is primary; antibiotics do not penetrate a walled-off abscess cavity, and the Cochrane evidence shows their added benefit over placebo is modest for uncomplicated lesions. If it is fluctuant, drain it.[1]

Everyone forgets the reservoir. Recurrent furunculosis that "keeps coming back" is being re-seeded from the patient's own nose or a household contact. Decolonise the patient, treat the contacts, and the cycle breaks; chasing each boil with a fresh antibiotic course never does.[2][3]

Consultant confession: the highest-yield question in a furuncle clinic is not "how big is it?" but "has anyone else in the house had one?". A yes points straight to PVL-positive household S. aureus — and to decolonisation of the whole family rather than yet another course of flucloxacillin for the index patient.[2][6]

The preventable-harm list:[1]

• Squeezing a facial furuncle in the danger triangle — cavernous sinus thrombosis.
• Treating a fluctuant abscess with antibiotics alone — drain it first.
• Missing PVL S. aureus in recurrent necrotic furunculosis — add clindamycin or linezolid and decolonise.
• Incising herpetic whitlow or an inflamed cyst thinking it is a boil — review morphology first.
• Missing the predisposing disease — undiagnosed diabetes, HIV or iron deficiency behind recurrent disease.
• Using fluoroquinolones or tetracyclines in children or pregnancy where they are contraindicated.

[1] [8]

The mantra: if it is fluctuant, drain it; if it recurs, decolonise; if it is facial, fear the cavernous sinus; and if it is necrotic in the young, suspect PVL.[1]

Prognosis, special populations and disposition

Most folliculitis and single furuncles resolve with drainage or a short topical course. Recurrence without decolonisation runs about 50 percent within a year; combined decolonisation and household treatment cuts it to 10 to 20 percent. Scarring is the main long-term sequel, especially on the scalp, beard and upper trunk.[1][2]

In children, favour topical antiseptics and judicious drainage; avoid fluoroquinolones and tetracyclines under 8 years, and decolonise the whole household. In pregnancy, flucloxacillin, cephalexin and erythromycin are safe; avoid tetracyclines and fluoroquinolones, but drainage remains primary. In diabetes, tighten glycaemic control to cut recurrence. Athletes are excluded from contact sport until lesions are healed and culture-negative.[1][17]

Primary care manages most disease. Refer or admit for systemic sepsis, a large carbuncle in diabetes or immunocompromise, danger-triangle lesions with systemic features, suspected PVL disease, or recurrent disease despite decolonisation.[1][8]

[1] [3]

The ward-round test

Click to reveal the stems — answer before you open each one

Stem 1. A healthy adult has a 2 cm fluctuant, tender furuncle on his thigh with no surrounding cellulitis and no fever. What is the primary treatment, and what is the role of antibiotics?[1]

Answer: Incision and drainage is the primary therapy; antibiotics are adjunctive and not needed for an uncomplicated drained lesion without cellulitis or systemic features. The Cochrane review shows the added benefit of antibiotics over placebo is modest here.[1]

Stem 2. A 19-year-old wrestler has his fourth necrotic furuncle in three months, and his teammate had one too. Name the likely organism, the toxin, and the antibiotic principle.[6][7]

Answer: PVL-producing S. aureus (Panton-Valentine leucocidin, a pore-forming leucocidin). Add a toxin-suppressing antibiotic — clindamycin or linezolid — plus drainage and household decolonisation; PVL status matters more than MSSA versus MRSA.[6][7]

Stem 3. A patient developed itchy follicular papules 24 hours after a hot-tub party, on the skin covered by her swimsuit. What is the organism, and what is the treatment?[10]

Answer: Pseudomonas aeruginosa hot-tub folliculitis, onset 8 to 48 hours after contaminated warm water. Usually self-limiting in 7 to 10 days; give ciprofloxacin 500 mg BD for 7 to 10 days only if severe or immunocompromised.[10]

Stem 4. A patient has a painful furuncle on his upper lip and you are about to squeeze it. Stop — what is the danger, and what do you do instead?[1]

Answer: A furuncle in the danger triangle drains via valveless facial veins to the cavernous sinus — squeezing risks cavernous sinus thrombosis. Do not squeeze; treat with urgent IV vancomycin or teicoplanin plus linezolid, ophthalmology and ENT input, and confirm with MRI or MRV.[1][8]

[1]

References

1. [1]Lin HS, Lin PT, Tsai YS, et al. Interventions for bacterial folliculitis and boils (furuncles and carbuncles) Cochrane Database Syst Rev, 2021.PMID 33634465
2. [2]Ibler KS, Kromann CB. Recurrent furunculosis - challenges and management: a review Clin Cosmet Investig Dermatol, 2014.PMID 24591845
3. [3]Sharara SL, Maragakis LL, Cosgrove SE. Decolonization of Staphylococcus aureus Infect Dis Clin North Am, 2021.PMID 33303331
4. [4]Piewngam P, Otto M. Staphylococcus aureus colonisation and strategies for decolonisation Lancet Microbe, 2024.PMID 38518792
5. [5]David MZ, Daum RS. Treatment of Staphylococcus aureus Infections Curr Top Microbiol Immunol, 2017.PMID 28900682
6. [6]Touaitia R, Mairi A, Ibrahim NA, et al. Staphylococcus aureus: A Review of the Pathogenesis and Virulence Mechanisms Antibiotics (Basel), 2025.PMID 40426537
7. [7]Jiang J-H, Cameron DR, Nethercott C, et al. Virulence attributes of successful methicillin-resistant Staphylococcus aureus lineages Clin Microbiol Rev, 2023.PMID 37982596
8. [8]Tong SYC, Fowler VG Jr, Skalla L, et al. Management of Staphylococcus aureus Bacteremia: A Review JAMA, 2025.PMID 40193249
9. [9]Toschi A, Giannella M, Viale P. Recurrence of skin and soft tissue infections: identifying risk factors and treatment strategies Curr Opin Infect Dis, 2025.PMID 39882704
10. [10]Spernovasilis N, Psichogiou M, Poulakou G. Skin manifestations of Pseudomonas aeruginosa infections Curr Opin Infect Dis, 2021.PMID 33492004
11. [11]Parker SR, Parker DC, McCall CO. Eosinophilic folliculitis in HIV-infected women: case series and review Am J Clin Dermatol, 2006.PMID 16734507
12. [12]Bobotsis R, Brathwaite S, Eshtiaghi P, et al. HIV: Inflammatory dermatoses Clin Dermatol, 2024.PMID 38142786
13. [13]Long H, Zhang G, Wang L, et al. Eosinophilic Skin Diseases: A Comprehensive Review Clin Rev Allergy Immunol, 2016.PMID 25876839
14. [14]Fulton JE Jr, McGinley K, Leyden J, et al. Gram-negative folliculitis in acne vulgaris Arch Dermatol, 1968.PMID 4234087
15. [15]Plewig G, Jansen T. Acneiform dermatoses Dermatology, 1998.PMID 9557242
16. [16]Sibaud V, Beylot-Barry M, Protin C, et al. Dermatological Toxicities of Bruton's Tyrosine Kinase Inhibitors Am J Clin Dermatol, 2020.PMID 32613545
17. [17]Zha M, Usatine R. Common Skin Conditions in Children and Adolescents: Bacterial Infections FP Essent, 2024.PMID 38896826
18. [18]Clebak KT, Malone MA. Skin Infections Prim Care, 2018.PMID 30115333